AnPac Bio-Medical Science Co Profit Margin

AnPac Bio-Medical Science Co (ANPC) currently reports a profit margin of -8.41% as of December 2022. That compares with -6.6% in the prior-year period — down 27.5% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore AnPac Bio-Medical Science Co's profit margin history and peer comparisons.

AnPac Bio-Medical Science Co's profit margin decreased from -6.6% to -8.41% — a 27.5% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AnPac Bio-Medical Science Co's profit margin of -8.41% is lower than the Healthcare sector average of 15.58%. That is roughly 5498.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but AnPac Bio-Medical Science Co's current -8.41% should be judged against Healthcare norms (sector average: 15.58%) and against ANPC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -8.41%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for AnPac Bio-Medical Science Co, and consider following ANPC for alerts when major investors trade the stock.